DexCom (DXCM) Misses Q4 EPS by 17c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $73.30 -3.99%
Revenue Growth %: +11.2%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: +11.2%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.17 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $698.2 million versus the consensus estimate of $696.47 million.
GUIDANCE:
DexCom sees FY2022 revenue of $2.82-2.94 billion, versus the consensus of $2.96 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- HCA Healthcare cuts 2026 profit outlook on insurance exchange losses
- IBM misses Q2 targets as mainframe and software sales disappoint
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
